Instil Bio (TIL) Common Equity (2020 - 2026)
Instil Bio's Common Equity was $107.38 million in Q2 2026, down 18.4% from $131.67 million a year earlier and down 3.0% from the prior quarter.
Powered by 
Analysis
Instil Bio (TIL) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Instil Bio came in at $113.87 million, down 32.8% from FY2024.
- Common Equity has now declined for four consecutive years.
- In earlier years, Common Equity was $169.44 million in FY2024 (-25.0%), $225.83 million in FY2023 (-37.9%), $363.61 million in FY2022 (-34.5%) and $555.2 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q4 2020.
- Compared with a year earlier, Common Equity has declined for 18 straight quarters, with an average decline of 27.3% over the last eight quarters.
- Across the past five years, year-over-year decline in Common Equity ran from 18.4% in Q2 2026 to 43.0% in Q3 2023.
- Per Business Quant data, TIL's Common Equity in the three quarters before Q2 2026 was $110.7 million (Q1 2026), $113.87 million (Q4 2025) and $120.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Instil Bio | 48.42 Mn | 48.42 Mn | - | 107.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.38 Mn |
| Mar 31, 2026 | 110.70 Mn |
| Dec 31, 2025 | 113.87 Mn |
| Sep 30, 2025 | 120.42 Mn |
| Jun 30, 2025 | 131.67 Mn |
| Mar 31, 2025 | 144.91 Mn |
| Dec 31, 2024 | 169.44 Mn |
| Sep 30, 2024 | 176.33 Mn |
| Jun 30, 2024 | 195.02 Mn |
| Mar 31, 2024 | 205.83 Mn |
| Dec 31, 2023 | 225.83 Mn |
| Sep 30, 2023 | 234.02 Mn |
| Jun 30, 2023 | 296.52 Mn |
| Mar 31, 2023 | 311.15 Mn |
| Dec 31, 2022 | 363.61 Mn |
| Sep 30, 2022 | 410.59 Mn |
| Jun 30, 2022 | 458.33 Mn |
| Mar 31, 2022 | 508.56 Mn |
| Dec 31, 2021 | 555.20 Mn |
| Sep 30, 2021 | 601.42 Mn |
API Access
Instil Bio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=TIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "TIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=TIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();